MORELLO, LUCIA
MORELLO, LUCIA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
2022 E. Calabretta, A. Guidetti, F. Ricci, M. Di Trani, C. Monfrini, M. Magagnoli, S. Bramanti, D. Maspero, L. Morello, M. Merli, A. Di Rocco, A. Graudenzi, E. Derenzini, M. Antoniotti, D. Rossi, P. Corradini, A. Santoro, C. Carlo-Stella
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse
2022 C. Rusconi, C.Y. Cheah, T.A. Eyre, D. Tucker, P. Klener, E. Gine, L. Crucitti, C. Muzi, S. Iadecola, G. Infante, S. Bernard, R.L. Auer, C. Pagani, M. Duglosz-Danecka, H. Mocikova, T. van Meerten, E. Cencini, A. Marin-Niebla, M.E. Williams, P. Angelillo, P. Nicoli, A. Arcari, L. Morello, D. Mannina, O. Vitagliano, R. Sartori, A. Chiappella, R. Sciarra, P.M. Stefani, M. Dreyling, J.F. Seymour, C. Visco
Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
---|---|---|---|---|---|
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics | 2022 | Guidetti, AnnaBramanti, StefaniaMorello, LuciaDerenzini, EnricoCorradini, Paolo + | Article (author) | - | |
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse | 2022 | Crucitti L.Infante G.Morello L. + | Article (author) | - |